Can Surgery Make Knee Osteoarthritis Worse? Here's What May Help Instead

Every year, nearly 800,000 total knee replacement surgeries are performed in the United States, making it one of the most common major procedures in modern medicine. For many patients with end-stage joint destruction, it is genuinely life-changing. But a different knee surgery - one performed far more frequently for the very same condition - has just been dealt a severe blow by a decade-long clinical trial whose findings should change how physicians and patients think about surgical intervention for knee osteoarthritis altogether.

The question is no longer simply "will surgery fix my knee?" The more important question, now backed by rigorous long-term evidence, is: could surgery actually be making this worse?

 

The Trial That Changed the Conversation

In May 2026, findings from a landmark 10-year clinical trial were published in correspondence in The New England Journal of Medicine, sending ripples through the orthopedics world. The study followed patients who had undergone partial meniscectomy - a procedure that involves surgically trimming or removing torn portions of the meniscus cartilage in the knee. The findings were unambiguous: patients who received the actual surgery fared significantly worse over the following decade than those who underwent a sham procedure in which no tissue was removed.

After 10 years, patients who had the real surgery reported more knee symptoms and poorer function. They showed greater osteoarthritis progression and were more likely to need additional knee surgery than those who received the placebo procedure. These were not marginal differences in ambiguous outcomes. They were clinically meaningful signals that one of the world's most widely performed knee procedures may be causing more harm than it prevents.

Teppo L.N. Järvinen, MD, PhD, of the University of Helsinki, one of the study's senior investigators, noted that in middle-aged and older individuals, meniscal tears are extremely common - including in people with no knee symptoms at all - making it unlikely the tear itself is usually the main driver of pain.

This is not an isolated finding. It fits into a broader pattern across medicine in which widely adopted treatments persist long after the evidence underlying them has shifted - or failed to materialize in the first place.

 

Understanding Knee Osteoarthritis: More Than Just Worn Cartilage

To understand why surgery so often fails to solve the problem, you first need to understand what osteoarthritis actually is at a biological level - and it is considerably more complex than the "bone rubbing on bone" explanation most patients receive.

Knee osteoarthritis is a degenerative joint disease characterized by cartilage degradation and synovial inflammation, which typically presents with joint stiffness, swelling, pain, and restricted mobility. But the description "degenerative" is misleading if it implies a purely passive wearing-away process. OA also involves active inflammatory processes and the destruction of joint tissue by proteolytic enzymes. Inflammation is not just a symptom of OA - it is a driver of its progression.

As OA worsens, bones of the affected joint weaken and deteriorate. Bone spurs or osteophytes form around the joints - outgrowths that may help stabilize the joint short-term, but can rub on other bones, nerves, and tissue, causing additional pain and further damage. Local release of inflammatory proteins recruits more immune cells, which in turn promote further inflammation and joint damage - a self-reinforcing cycle that surgery does nothing to interrupt at the molecular level.

Knee OA accounts for nearly 85% of the total disease burden of OA globally, affecting an estimated 17 million Americans aged 45 and older. Pain in a knee with OA arises from multiple simultaneous sources - inflamed synovium, sensitized nociceptors, subchondral bone lesions, structural deformity, and central nervous system sensitization. This explains why removing one visible structural finding rarely resolves the pain experience completely.

 

Why the Surgical Default Has Persisted Despite the Evidence

Partial meniscectomy and other arthroscopic knee procedures became widely adopted based on plausible biological logic, high patient demand, and early uncontrolled observational studies. Before rigorous sham-controlled trials existed, the fact that patients reported feeling better after surgery seemed like proof the surgery worked. But widely used treatments can persist despite limited evidence, and when tested rigorously with proper controls, may turn out to offer little benefit - or even cause harm.

The field of orthopedics is now in a difficult reckoning. Knee osteoarthritis is the leading cause of total knee replacement surgery, with nearly 800,000 procedures performed each year in the United States. Yet up to 20% of patients still experience chronic pain after total knee replacement. A procedural answer to a fundamentally inflammatory, neurological, and systemic condition has predictable limits.

Total knee replacement occupies a different clinical position than arthroscopic procedures. For patients with advanced grade 3 or grade 4 osteoarthritis who have failed all conservative management, total knee replacement has demonstrated meaningful improvement in pain and function scores. Conservative treatment alone improves symptoms noticeably in 67% of patients, while knee replacement combined with conservative treatment improves symptoms in approximately 85% - meaning surgery does confer an advantage in severe end-stage disease, but conservative treatment alone is effective for most patients.

The critical takeaway is that surgery - particularly less invasive arthroscopic procedures - should not be the first or default response to knee OA pain, and for many patients, it should not be on the table at all until a rigorous, sustained course of non-surgical management has been genuinely explored.

 

The Problem With Long-Term Painkillers

When surgery is off the table - or has already failed - most patients are handed a prescription for NSAIDs and told to manage from there. This approach is not unreasonable for short-term pain control, but the long-term picture is troubling.

A prospective multi-cohort study analyzing 4,197 participants across three major osteoarthritis cohorts found that long-term NSAID users were significantly more likely to experience aggravated pain, worsened disability, greater stiffness, and total knee replacement compared to non-users over 4 to 5 years. The very medication most commonly prescribed for knee OA may be accelerating the disease trajectory - not just masking it.

Long-term NSAID use carries significant documented risks including gastrointestinal bleeding, increased cardiovascular events, and kidney damage. Crucially, neither NSAIDs nor COX-2 inhibitors stop or restore the loss of articular cartilage - the hallmark of osteoarthritis. They are purely palliative. Find out more about the risks of long-term painkiller dependence and safer strategies in this article on NSAID risks and joint health at Naturem.

Opioids represent an even more problematic escalation. Opioid use in OA is associated with acute and chronic side effects including drowsiness, dizziness, constipation, nausea, and significant potential for dependence - while potentially worsening the underlying joint structure over time.

 

What Actually Helps: The Evidence-Based Non-Surgical Toolkit

The good news is that an increasingly robust body of clinical evidence supports a range of non-surgical interventions - from structured exercise and weight management to targeted nutraceuticals and traditional herbal medicine - that address both the symptoms and the underlying biology of knee OA.

Exercise and Physical Therapy - The Most Underutilized Treatment

The single most consistently supported intervention for knee osteoarthritis in clinical guidelines is exercise. OARSI guidelines list supervised exercise as the core first-line treatment for knee OA, with strong evidence for both land-based and aquatic programs. Exercise improves joint lubrication by stimulating synovial fluid production, strengthens the periarticular muscles that stabilize and protect the joint, reduces systemic inflammatory markers, and modulates the central sensitization that amplifies pain perception in chronic OA.

Research confirms that controlling joint instability through targeted rehabilitation reduces inflammatory pain-related factors produced in periarticular tissues, directly decreasing both nociceptive and neuropathic-like pain components in knee OA. Targeted strengthening of the quadriceps, hamstrings, and hip abductors reduces biomechanical load on the medial joint compartment - the area where most knee OA initiates - in a way no pill or procedure can replicate.

Recommended exercise modalities for knee OA include:

• Quadriceps-focused resistance training (leg press, wall slides, straight-leg raises)
• Low-impact aerobic conditioning (cycling, swimming, walking)
• Aquatic therapy, which reduces joint loading while allowing full range-of-motion movement
• Tai chi, which has demonstrated improvements in pain, balance, and function in multiple randomized controlled trials

Weight Management - Every Kilogram Counts

Each kilogram of body weight exerts approximately 3-6 kilograms of compressive force on the knee joint during walking. Even modest weight reduction therefore has an outsized mechanical benefit on a diseased joint. Beyond mechanics, excess body fat elevates circulating levels of pro-inflammatory cytokines including interleukin-6 and TNF-alpha, which directly contribute to cartilage degradation and synovial inflammation in OA. Weight management is therefore both a mechanical and a biological intervention for knee OA.

Boswellia Serrata - One of the Most Evidence-Backed Natural Anti-Inflammatories

Boswellic acids, derived from the resin of Boswellia serrata trees and long used in Ayurvedic medicine, have been shown in multiple randomized controlled trials to suppress inflammatory mediators and ameliorate synovitis in knee osteoarthritis. A 2025 network meta-analysis concluded that Boswellia appeared to be both effective and well-tolerated for improving symptoms and function - outperforming several other commonly used supplements in comparative efficacy.

A randomized clinical trial comparing MSM combined with boswellic acids against glucosamine sulfate in 120 knee arthritis patients found that both produced significant improvements in visual analog pain scores and joint function at 2 and 6 months. Boswellic acids work by selectively inhibiting 5-lipoxygenase (5-LOX), an enzyme central to the production of pro-inflammatory leukotrienes - a mechanism distinct from NSAIDs that allows anti-inflammatory benefit without gastrointestinal and cardiovascular risks.

Collagen Peptides - Rebuilding from the Inside Out

Cartilage has almost no intrinsic blood supply, which severely limits its ability to regenerate. This is why most interventions that simply reduce inflammation or block pain enzymes fail to reverse structural progression. Collagen peptides represent a different approach: providing the substrate from which chondrocytes can produce new extracellular matrix components.

A randomized controlled trial found that specific bioactive collagen peptides significantly decreased activity-related knee pain in adults with functional knee discomfort, with improvements in both pain scores and joint mobility over 12 weeks. Pre-clinical evidence shows that collagen peptides stimulate chondrocytes to synthesize cartilage matrix macromolecules, and their high proportion of proline and hydroxyproline gives them a unique ability to resist intestinal degradation and reach joint tissues intact.

A 2023 review confirmed that both native and hydrolyzed collagen have demonstrated chondroprotective effects in clinical studies. For a natural formulation that combines collagen support with complementary joint-health ingredients, find out more about Naturem Joints+ and how it supports joint structure from multiple biological angles.

Glucosamine and Chondroitin Sulfate - Foundational Cartilage Support

Glucosamine and chondroitin sulfate are naturally occurring structural components of joint cartilage and synovial fluid. A systematic review found that pharmaceutical-grade glucosamine sulfate showed statistically significant effects on pain and function in knee OA, with product quality found to significantly influence outcomes.

Chondroitin combined with glucosamine was found in a multicenter randomized trial to be non-inferior to celecoxib for pain reduction in patients with painful knee OA - a finding with significant implications for those seeking to reduce pharmaceutical drug burden. Both compounds work by inhibiting cartilage-degrading enzymes and providing building blocks for proteoglycan synthesis, the structural protein matrix that gives cartilage its shock-absorbing properties.

Drynaria Fortunei - Traditional Bone Medicine Meets Modern Science

One of the most fascinating ingredients at the intersection of traditional medicine and contemporary joint research is Drynaria fortunei, known in traditional Chinese medicine as Gu-Sui-Bu. First documented in ancient Chinese herbology texts dating to 739 C.E., Drynaria fortunei has been used for over a millennium to treat bone fractures, bone pain, and musculoskeletal disorders.

Modern research is now providing mechanistic clarity for this traditional application. Studies confirm that Drynaria fortunei stimulates osteoblast proliferation - the bone-forming cells responsible for new bone deposition - and inhibits osteoclast activity, the cells that break bone down. Its total flavonoids also exert anti-inflammatory and immunomodulatory effects directly relevant to OA joint damage.

Drynaria fortunei also promotes angiogenesis - the formation of new blood vessels - which is particularly important for joint tissues that have limited blood supply and therefore limited access to the oxygen and nutrients needed for repair. By improving circulation to bone and periarticular tissue, it addresses one of the fundamental obstacles to joint recovery that most supplements ignore entirely. Find out more about why glucosamine alone falls short for joint repair and how Drynaria fortunei improves circulation and bone density at Naturem.

Omega-3 Fatty Acids - Modulating the Inflammatory Cascade

Omega-3 polyunsaturated fatty acids - particularly EPA and DHA - have been shown in clinical research to improve the joint inflammatory microenvironment in OA by reducing pro-inflammatory prostaglandin production and supporting the resolution of chronic synovial inflammation. Krill oil, which contains omega-3s in a highly bioavailable phospholipid form, has been specifically noted in comparative supplement analyses for knee OA for its ability to modulate the joint microenvironment.

The relevance of omega-3s extends beyond joint-specific effects. Systemic inflammation is now understood to be a key accelerator of OA progression. Reducing the inflammatory burden at the systemic level through nutritional intervention complements all other forms of joint management. Discover how algal omega-3 supports inflammation management and why plant-derived omega-3 is increasingly the preferred form for consistent daily supplementation.

Curcumin - Targeting the NF-kB Pathway

Curcumin, the primary active polyphenol in turmeric, works by inhibiting the NF-kB transcription factor - a master regulator of inflammatory gene expression that drives the production of inflammatory cytokines, prostaglandins, and matrix metalloproteinases that degrade cartilage collagen in OA. Its anti-inflammatory mechanism is genuinely distinct from NSAIDs, offering benefit without the gastrointestinal or cardiovascular risks of COX inhibition.

In vitro and animal studies consistently demonstrate curcumin's ability to inhibit cartilage degradation, reduce synovial inflammation, and suppress joint pain-related nociceptive signaling. The main clinical challenge is bioavailability. Formulations that combine curcumin with piperine from black pepper - shown to enhance absorption by up to 2,000% - or liposomal forms, are significantly more clinically relevant than standard preparations.

 

Building a Comprehensive Non-Surgical Management Plan

The most effective non-surgical approach to knee OA is not one ingredient or one therapy - it is a multi-modal strategy that addresses the mechanical, inflammatory, structural, and neurological dimensions of the disease simultaneously. Based on current clinical evidence, a comprehensive plan should include:

Physical movement as medicine: Structured exercise targeting muscular stabilization and cardiovascular conditioning, performed consistently 3-5 times per week, guided by a physiotherapist familiar with OA management.

Weight optimization: Even a 5-10% reduction in body weight can produce meaningful reductions in knee loading and systemic inflammatory burden - and should be a primary target for overweight individuals with knee OA.

Anti-inflammatory nutrition: A diet rich in polyphenols, omega-3 fatty acids, and low in refined carbohydrates and processed foods directly modulates the systemic inflammatory milieu that drives OA progression.

Evidence-based supplementation: A combination of glucosamine sulfate and chondroitin, collagen peptides, Boswellia extract, omega-3 fatty acids, and curcumin represents a multi-targeted approach to joint support. For those seeking a formulated option that integrates collagen peptides, Drynaria fortunei, and circulatory support in a single product, the Joints+ formula at Naturem is designed specifically to support joint health from multiple biological angles.

Mindful use of pain medication: NSAIDs should be used at the lowest effective dose for the shortest necessary duration, and only as part of a broader management strategy - not as a standalone or indefinite solution.

Regular reassessment: OA is a dynamic condition. Working with a rheumatologist or integrative medicine practitioner who takes a comprehensive view of the condition is essential to optimizing long-term outcomes.

 

When Surgery Is Still Appropriate

None of this means surgery is never the right answer for knee OA. For patients with end-stage grade 3 or grade 4 disease who have genuinely failed all conservative management, total knee replacement remains an effective intervention with demonstrated improvements in pain and function. The critical qualifier is "genuinely failed" - not "tried for six weeks before seeking a referral."

Conservative treatment is effective even in most people with advanced osteoarthritis, and can help delay or avoid the need for knee surgery altogether. The standard of care should be structured, sustained, and comprehensively implemented non-surgical management first - with surgery reserved for those who have exhausted these options over a meaningful period of time.

For arthroscopic procedures like partial meniscectomy, the current evidence is now clear enough to counsel patients directly: the procedure is not supported by high-quality trial data, and the latest long-term evidence suggests it may accelerate rather than resolve OA progression. Patients being offered arthroscopic knee surgery for OA-related pain deserve to know this before they consent.

 

The Future of Knee OA Treatment

The trajectory of research is encouraging. The Advanced Research Projects Agency for Health (ARPA-H) has committed an initial $13 million in funding to the NITRO (Novel Innovations for Tissue Regeneration in Osteoarthritis) program, specifically aimed at developing regenerative therapies that could allow cartilage repair and help people with OA avoid surgery and stay active. Biologic injections, targeted gene therapy, and cartilage scaffolding technologies are all advancing through research pipelines.

But those solutions are years away from widespread clinical availability. In the meantime, the tools that exist today - exercise, weight management, evidence-based supplementation, and dietary anti-inflammatory strategies - are far more powerful than most patients and even many clinicians appreciate.

The evidence that one of the most common knee surgeries may be making the condition worse is not a cause for despair. It is a call to take non-surgical management seriously, implement it comprehensively, and give it the time and consistency it requires to work.

Your knees did not deteriorate overnight. The most effective path to preserving them runs through patience, consistency, and a commitment to treating the biological root of the problem - not just its most visible structural manifestation.

The information provided in this article is intended for general educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. It should not be used as a substitute for professional medical guidance from a qualified physician, specialist, or licensed healthcare provider. Always consult your doctor or a qualified health professional before making any changes to your diet, supplement routine, exercise program, or treatment plan.

Frequently Asked Questions (FAQs)

1. Can knee osteoarthritis be reversed without surgery?

Knee osteoarthritis cannot currently be fully reversed, but its progression can be meaningfully slowed and symptoms significantly reduced without surgery. Clinical evidence consistently shows that structured exercise, weight management, and targeted supplementation can improve pain, mobility, and joint function - often to a degree comparable to surgical outcomes. Conservative treatment alone produces noticeable symptom improvement in the majority of patients, and can delay or entirely avoid the need for surgical intervention. (NCBI, 2024; Duke Health, 2026)

2. Is partial meniscectomy a safe and effective treatment for knee OA pain?

Recent long-term evidence challenges this assumption directly. A 10-year clinical trial published in correspondence in The New England Journal of Medicine found that patients who underwent partial meniscectomy reported more knee symptoms, poorer function, and faster osteoarthritis progression compared to those who received a sham procedure. Experts now argue that the meniscal tear, while visible on imaging, is frequently not the primary driver of pain in middle-aged and older adults with knee OA. (Medical News Today, 2026; ScienceDaily, 2026)

3. What natural supplements have the strongest clinical evidence for knee osteoarthritis?

A 2025 network meta-analysis identified Boswellia serrata as one of the most effective and well-tolerated nutritional supplements for improving knee OA symptoms and function. Glucosamine sulfate combined with chondroitin has been shown in randomized trials to be non-inferior to celecoxib for pain reduction. Collagen peptides have demonstrated the ability to stimulate chondrocyte activity and reduce activity-related knee pain in controlled trials. Omega-3 fatty acids help modulate the joint inflammatory microenvironment, and curcumin targets the NF-kB inflammatory pathway relevant to cartilage degradation. (NCBI, 2025; NCBI, 2023; NCBI, 2016)

4. Are long-term NSAIDs safe for managing chronic knee osteoarthritis pain?

Long-term NSAID use carries significant documented risks and may worsen osteoarthritis outcomes over time. A prospective multi-cohort study following over 4,000 participants found that long-term NSAID users were more than twice as likely to experience worsened pain and disability, and over three times more likely to require total knee replacement compared to non-users. NSAIDs also carry well-established risks for gastrointestinal bleeding, cardiovascular events, and kidney damage, and do not repair or slow cartilage loss. They should be used at the lowest effective dose for the shortest necessary duration. (NCBI, 2024; PLOS ONE, 2025)

5. What role does Drynaria fortunei play in joint and bone health?

Drynaria fortunei, known in traditional Chinese medicine as Gu-Sui-Bu, has been used since 739 C.E. to treat bone fractures and musculoskeletal disorders. Modern research confirms it stimulates osteoblast proliferation (bone-forming cells), inhibits osteoclast activity (bone-resorbing cells), and promotes angiogenesis - improving blood flow and nutrient delivery to joint tissues that have limited natural circulation. Its total flavonoids also exert anti-inflammatory and immunomodulatory effects directly relevant to OA joint damage. These combined mechanisms make it distinct from glucosamine, which acts primarily on cartilage rather than the subchondral bone underlying it. (ScienceDirect, 2025; NCBI, 2020)

References

Alman, B., & Duke NITRO Research Team. (2026). New research brings joint repair closer for millions with osteoarthritis. Duke Health. https://corporate.dukehealth.org/news/new-research-brings-joint-repair-closer-millions-osteoarthritis

Bannuru, R. R., Osani, M. C., Vaysbrot, E. E., Arden, N. K., Bennell, K., Bierma-Zeinstra, S. M. A., Kraus, V. B., Lohmander, L. S., Abbott, J. H., Bhandari, M., Blanco, F. J., Espinosa, R., Haugen, I. K., Lin, J., Mandl, L. A., Moilanen, E., Nakamura, N., Snyder-Mackler, L., Trojian, T., … McAlindon, T. E. (2019). OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis and Cartilage, 27(11), 1578-1589. https://pubmed.ncbi.nlm.nih.gov/26684635/

Bhatt, D. L., Scheiman, J., Abraham, N. S., Antman, E. M., Chan, F. K. L., Furberg, C. D., Johnson, D. A., Mahaffey, K. W., & Quigley, E. M. (2008). ACCF/ACG/AHA expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Circulation, 118(18), 1894-1909. https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0320379

Dong, G. C., Ma, T. Y., Li, C. H., Chi, C. Y., Su, C. M., Huang, C. L., Wang, Y. H., & Lee, T. M. (2020). A study of Drynaria fortunei in modulation of BMP-2 signalling by bone tissue engineering. Turkish Journal of Biology, 44(4), 230-241. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491309/

Grover, A. K., & Samson, S. E. (2016). Benefits of antioxidant supplements for knee osteoarthritis: Rationale and reality. Nutrition Journal, 15(1), 1-10. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700773/

Hamed, M., & Ibrahim, M. (2025). Comparative effectiveness of nutritional supplements in the treatment of knee osteoarthritis: A network meta-analysis. BMC Musculoskeletal Disorders. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12348802/

InformedHealth.org. (2024). Osteoarthritis of the knee: Joint replacement in osteoarthritis of the knee. National Center for Biotechnology Information Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK544983/

Järvinen, T. L. N., & Finnish Degenerative Meniscal Lesion Study (FIDELITY) Group. (2026). Partial meniscectomy versus sham surgery for a degenerative meniscal tear: 10-year follow-up. The New England Journal of Medicine (correspondence). Referenced via: https://www.medicalnewstoday.com/articles/surgery-may-worsen-knee-osteoarthritis-what-could-help

Kuroo, A., Murata, K., Morishita, Y., Onitsuka, K., Oka, Y., Tanaka, K., & Kanemura, N. (2025). Controlling joint instability reduces inflammatory pain in early knee osteoarthritis. Cureus, 17(7), e87711. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12335746/

Li, P., Zheng, Y., & Chen, X. (2015). Drynaria fortunei promoted angiogenesis associated with modified MMP-2/TIMP-2 balance and activation of VEGF ligand/receptors expression. Frontiers in Pharmacology, 9, 1068. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160574/

Life Extension. (2024). Osteoarthritis: Disease management protocol. Life Extension Foundation. https://www.lifeextension.com/protocols/immune-connective-joint/osteoarthritis

Martínez-Puig, D., Costa-Larrión, E., Rubio-Rodríguez, N., & Gálvez-Martín, P. (2023). Collagen supplementation for joint health: The link between composition and scientific knowledge. Nutrients, 15(6), 1332. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058045/

Medical News Today. (2026). Knee osteoarthritis: Could surgery actually worsen it? Medical News Today. https://www.medicalnewstoday.com/articles/surgery-may-worsen-knee-osteoarthritis-what-could-help

Nakamura, H., Masuko, K., Yudoh, K., Kato, T., Nishioka, K., Sugihara, T., & Beppu, M. (2018). Effects of glucosamine in patients with osteoarthritis of the knee: A systematic review and meta-analysis. Therapeutics and Clinical Risk Management, 14, 1661-1671. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097075/